Cargando…
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) has been associated with an abnormal lipid profile. Apolipoprotein C-III (ApoC3) is a key molecule of triglyceride metabolism that is known to be related to inflammation and cardiovascular disease. In this study, we aim to study whether ApoC3 serum levels differ betw...
Autores principales: | Hernández-Camba, Alejandro, Carrillo-Palau, Marta, Ramos, Laura, de Armas-Rillo, Laura, Vela, Milagros, Arranz, Laura, González-Gay, Miguel Á., Ferraz-Amaro, Iván |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236603/ https://www.ncbi.nlm.nih.gov/pubmed/35584319 http://dx.doi.org/10.14309/ctg.0000000000000500 |
Ejemplares similares
-
Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk
por: Hernández-Camba, Alejandro, et al.
Publicado: (2021) -
Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease
por: Rodríguez-Hernández, Orvelindo, et al.
Publicado: (2023) -
Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021) -
QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021) -
The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
por: de Armas-Rillo, Laura, et al.
Publicado: (2022)